Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Protagonist Therapeutics Inc (PTGX)

Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate ACCESSWIRE - Thu Nov 21, 10:05AM CST

Oral peptide with biologics-like high potency and spectrum of activity against three therapeutically relevant dimeric forms of IL-17 (AA, AF and FF)

PTGX : 41.65 (+2.46%)
Protagonist Therapeutics to Host Conference Call to Announce an Oral Peptide IL-17 Antagonist Development Candidate ACCESSWIRE - Tue Nov 19, 1:30AM CST

Webcast and conference call to be held be on Thursday, November 21st at 4:30 pm ET, dial in information below

PTGX : 41.65 (+2.46%)
Protagonist Therapeutics: Q3 Earnings Snapshot AP - Thu Nov 7, 3:56PM CST

Protagonist Therapeutics: Q3 Earnings Snapshot

PTGX : 41.65 (+2.46%)
Protagonist Therapeutics: Q2 Earnings Snapshot AP - Tue Aug 6, 6:18AM CDT

Protagonist Therapeutics: Q2 Earnings Snapshot

PTGX : 41.65 (+2.46%)
Preclinical and Clinical Pharmacokinetic, Pharmacodynamic, and Safety Data of Targeted Oral Peptide JNJ-2113 Published in Scientific Reports ACCESSWIRE - Thu Aug 1, 6:00AM CDT

NEWARK, CA / ACCESSWIRE / August 1, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced publication of preclinical and phase 1 clinical data on JNJ-2113 in the journal...

PTGX : 41.65 (+2.46%)
Nike, Kura Sushi fall; Infinera, Protagonist Therapeutics rise, Friday, 6/28/2024 Associated Press - Fri Jun 28, 3:13PM CDT

Stocks that traded heavily or had substantial price changes on Friday: Nike, Kura Sushi fall; Infinera, Protagonist Therapeutics rise

FCX : 43.76 (+0.14%)
PTCT : 42.89 (+2.22%)
ACCD : 3.71 (+4.21%)
KRUS : 95.54 (+7.19%)
PTGX : 41.65 (+2.46%)
INFN : 6.61 (unch)
Protagonist Therapeutics Announces Oral Presentation on Long-Term Follow-up of Rusfertide Phase 2 REVIVE Study Open Label Extension at the European Hematology Association 2024 Congress ACCESSWIRE - Tue May 14, 11:05AM CDT

NEWARK, CA / ACCESSWIRE / May 14, 2024 / Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ("Protagonist" or the "Company") today announced that additional data from the rusfertide Phase 2 REVIVE open label...

PTGX : 41.65 (+2.46%)
Protagonist Therapeutics: Q1 Earnings Snapshot AP - Tue May 7, 3:23PM CDT

Protagonist Therapeutics: Q1 Earnings Snapshot

PTGX : 41.65 (+2.46%)
Protagonist Therapeutics: Q4 Earnings Snapshot AP - Tue Feb 27, 3:38PM CST

Protagonist Therapeutics: Q4 Earnings Snapshot

PTGX : 41.65 (+2.46%)
Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On Motley Fool - Thu Nov 16, 2023

Unsurprisingly, Johnson & Johnson's top investments are all in the healthcare sector.

NVS : 103.85 (+0.74%)
JNJ : 155.50 (+1.56%)
LEGN : 39.75 (-0.97%)
CVRX : 14.77 (+9.25%)
PTGX : 41.65 (+2.46%)

Barchart Exclusives

1 AI Stock to Buy and Hold for Long-Term Growth Barchart - 31 minutes ago
Pure Storage stands out in AI data storage, bolstered by a new partnership with CoreWeave and a solid financial track record, making it an intriguing stock for AI-focused investors Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot